Newsletter - All News

Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research

Category
Continent
From
To
 
Argo Biopharma Secures IND Approval for Phase II T...

Argo Biopharma Secures IND Approval for Phase II T...

Category : Approval/Launch 16 September 2025

Beijing, China — Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage siRNA the...
Seaport Therapeutics Doses First Participant in Ph...

Seaport Therapeutics Doses First Participant in Ph...

Category : Clinical Trial Update 15 September 2025

PureTech Health plc announced that its founded entity, Seaport Therapeutics, has dosed the first par...
Philips and Masimo Renew Strategic Partnership to...

Philips and Masimo Renew Strategic Partnership to...

Category : Licensing/Collaboration Deal 15 September 2025

Royal Philips and Masimo have renewed their multi-year strategic collaboration, deepening their long...
Merck announces positive results from phase 3 STRI...

Merck announces positive results from phase 3 STRI...

Category : Clinical Trial Update 12 September 2025

"Merck, known as MSD outside of the United States and Canada, announced positive results from t...
Scipher Medicine Enters into Partnership with Maxy...

Scipher Medicine Enters into Partnership with Maxy...

Category : Licensing/Collaboration Deal 12 September 2025

"Scipher Medicine has entered into a strategic collaboration with Maxymune Therapeutics. ...

Categories

Latest Newsletter Post

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!